CAS: 23672-07-3; (S)-N-((1-Ethylpyrrolidin-2-yl)Methyl)-2-Methoxy-5-Sulfamoylbenzamide

结构式图片

上下游产品

2-methoxy-5-sulfamoylbenzoic acid ethyl ester (S)-2-(Aminomethyl)-1-ethylpyrrolidine methyl 2-methoxy-5-sulfamoyl-benzoate(S)-3-(((1-ethylpyrrolidin-2-yl)methyl)carbamoyl)-4-methoxybenzenesulfonyl azide

合成工艺路线路线简述

    舒必利 反应生成左舒必利
    参考文献:Al-Koutayni-Rifai,M.;Jamet,G.;Kerr,R. R.;Jung,L.;Koffel,J. C.,J. Labell. Compounds And Radiopharm.,27,(1989) N,C. 811-821
    标题:Al-Koutayni-Rifai,M.;Jamet,G.;Kerr,R. R.;Jung,L.;Koffel,J. C.,J. Labell. Compounds And Radiopharm.,27,(1989) N,C. 811-821

    海关参考信息

    专利信息


    专利号:EP-0596485-B1
    优先权日:1992-11-05
    标题 :Electrochemical process for preparing alcoholates of alkaline metal and use thereof for regenaration of the catalyst in the synthesis of methylformat
    发明人:SOBOTTA GEORG DR-ING; PAZDERSKI JURI ANTONOWITSCH PR; SKATSCHKO WLADIMIR PETROWITSCH; LEZJUK WASSILI WLADIMIROWITSCH; TAGAJEW OLEG ALEXEJEWITSCH DR
    权利人:SALZGITTER ANLAGENBAU; SYNTHEZ BNII
    摘要:The invention relates to a process for the electrochemical synthesis of alkali metal alcoholates (alkoxides) and/or for the regeneration of the catalyst from methyl formate synthesis from alcoholic solutions of salts of alkali metals in an electrolysis apparatus with an ion-selective membrane. The electrolysis is carried out in the presence of a defined quantity of a potassium salt or sodium salt of a perfluoroalkanesulphonic acid accompanied by the use of non-oxidisable anode material and with a membrane based on a sulphonated styrene-divinylbenzene copolymer. The process enables an increase in the selectivity of the procedure and a continuous synthesis.

    专利号:US-10005720-B2
    优先权日:2013-04-05
    标题:Compounds useful for the treatment of metabolic disorders and synthesis of the same
    发明人:SEXTON JONATHAN Z; BRENMAN JAY E; MUSSO DAVID L
    权利人:NORTH CAROLINA CENTRAL UNIV; UNIV NORTH CAROLINA CHAPEL HILL
    摘要:The present invention provides compounds of Formula (I): wherein variables X, Y, Z and R1 are as described herein. Some of the compounds described herein are glutamate dehydrogenase activators. The invention is also directed to pharmaceutical compositions comprising these compounds, uses of these compounds and compositions in the treatment of metabolic disorders as well as synthesis of the compounds.

    专利号:WO-03055857-A8
    优先权日:2001-12-28
    标题 :A process for synthesis of heterocyclic aminoalkyl benzamides
    发明人:STANKOVIC SLOBODAN; MITOV SLOBODAN; STANOJEVIC CASLAV; PESIC LJILJANA
    权利人:FARMACEUTSKO HEMIJSKA IND ZDRA; STANKOVIC SLOBODAN; MITOV SLOBODAN; STANOJEVIC CASLAV; PESIC LJILJANA
    摘要:The simple, new, original and convenient for use, procedure for obtaining of compounds, belonging to the group of $i(heterocyclic aminoalkyl benzamides) of general formula 1, is developed, and/or salts and/or hydrates and/or optical isomers thereof, wherein R1 and R2 denote C1-C4 $i(alkyl) group, R3 denotes an $i(aminosulphonyl) group, denotes a $i(hydrogen) atom or an $i(amino) group, R5 denotes a $i(hydrogen) or a $i(halogen) atom, and and the coefficients $i(m )and $i(n) have value of 1 and/or 2. Of a particular interest in clinical practice are: $i(sulpiride )(RS, R+ or S-)-(5-$i(aminosulphonyl))-N-/(1-$i(ethyl)-2-$i(pyrrolidinyl))$i(methyl)/-2-$i(methoxybenzamide)) and sulmepride (RS, R+ or S-)-(5-($i(aminosulphonyl))-2-$i(methoxy)-N-/-(1-$i(methyl-)2-$i(pyrrolidinyl)methyl/benzamide)). The compounds belonging to this group are used in therapy as: antipsychotics, anti depressives and anti emetics, fungicides, for contraceptive mixtures, in treatment of sterility, as radiopharmaceutical compositions in nuclear medicine, in treatment of migraine of various origins, as well as in treatment of parkinsonism. The advantage of the present invention is in its completely new and simple way to carry out the synthesis of $i(heterocyclic aminoalkyl benzamides )and/or salts and/or hydrates thereof, through reaction of $i(2-alcoxy-5-suiphamoyl-alkyl benzoate )with the corresponding (RS R+ or S-) heterocyclic amine. )Lower temperature of rection and work at atmospheric pressure without catalysts, performing the reaction in cheaper and safer organic solvents, i obtaining the final product which does not require any additional purification, achieving of I good yield and high quality of the final product, cheaper procedure for industrial use and obtaining of the product of high pharmacopeic purity.

    专利号:US-5468876-A
    优先权日:1986-05-22
    标题:Intermediates for the stereoconservative synthesis of 1-substituted (S)-and (R)-2-aminomethylpyrrolidines
    发明人:FEDERSEL HANS-JUEGEN; HOE THOMAS; RAEMSBY STEN I; STROEM PETER H E
    权利人:ASTRA AB
    摘要:Disclosed are (R)- and (S)-isomers of the compounds of the Formulas II and III with at least 95% optical purity ##STR1## wherein R 1 and R 2 are the same or different and represent a hydrogen atom, a lower alkyl, lower alkenyl or lower alkynyl group, a cycloalkyl group or a group (CH 2 ) m Ph, wherein m is 0-3 and Ph is a substituted or unsubstituted phenyl group. n These compounds are intermediates in the stereoconservative synthesis of 1-substituted (S)- and (R)-2-aminomethylpyrrolidines.

    专利号:US-7576211-B2
    优先权日:2004-09-30
    标题 :Synthesis of thienopyridinone compounds and related intermediates
    发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; CHEN DONGLI; MARANTZ YAEL; SHACHAM SHARON; HEIFETZ ALEXANDER; INBAL BOAZ; BAR-HAIM SHAY; MOHANTY PRADYUMNA; LOBERA MERCEDES; WU LAURENCE
    权利人:EPIX DELAWARE INC
    摘要:The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.

    专利号:WO-2016123658-A1
    优先权日:2015-02-08
    标题:Solid state synthesis of polyaromatic hydrocarbons and their hydrides
    发明人:WHITE BRUCE WILLIAM
    权利人:NOVELCHEM AUSTRALIA PTY LTD
    摘要:A process of dehydrogenation of hydrocarbons in a closed reactor by the action of oxidants under beat and pressure and time and presents as a solid-state process is disclosed. The reactor contains absorbents in situ to remove any unwanted products as the dehydrogenation proceeds. The process could be employed as a useful step in relevant organic synthesis work in future. In a specific example, a process of synthesising fullerene hydrides is described.
    江苏天士力帝益药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.taslydiyi.com
    电话: 0517-80889600👤
    📞江苏天士力帝益药业有限公司 ⚠️参考联系方式

    销售电话:0517-80889600
    邮箱:xiupeng@tasly.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    台州开创生物医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.creatingbiopharm.com
    企业联系电话:0576-88827176;18906581668👤
    📞台州开创生物医药有限公司 ⚠️参考联系方式
    联系人:余美平
    电话:0576-88827176;18906581668
    手机:13586099526;18906581668
    传真:0576-88822496
    邮箱:sales@creatingbiopharm.com
    通信地址: 浙江省台州市君悦大厦A幢715
    邮编: 318000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省台州市君悦大厦A幢715
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    厦门环华有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.china-sinoway.com
    企业联系电话:86-592-5853819👤
    📞厦门环华有限公司 ⚠️参考联系方式
    联系人:谢先生
    电话:86-592-5853819

    传真:86-592-5854960
    邮箱:xie@china-sinoway.com
    通信地址: 厦门厦禾路839号汇成商业中心16楼
    邮编: 361004
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:厦门厦禾路839号汇成商业中心16楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    台州市博纳化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.tzbnchem.com
    企业联系电话:0576-88663272👤
    📞台州市博纳化工有限公司 ⚠️参考联系方式
    联系人:陈
    电话:0576-88663272

    传真:0576-88707069
    邮箱:sales@tzbnchem.com
    通信地址: 浙江省台州市椒江区外沙工业园区
    邮编: 318000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省台州市椒江区外沙工业园区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Bryan EJ, Purcell MA, Kumar A. Zuclopenthixol dihydrochloride for schizophrenia. Cochrane Database Syst Rev. 2017 Nov 16;11:CD005474. doi: 10.1002/14651858.CD005474.pub2. Review. doi: 10.1002/14651858.CD010832.pub2. Review. doi: 10.1016/j.phrs.2015.12.029. Epub 2015 Dec 31. Review. doi: 10.1002/14651858.CD011681. Review. doi: 10.1093/schbul/sbv019. Epub 2015 Mar 18. Review.
    6: McLoughlin BC, Pushpa-Rajah JA, Gillies D, Rathbone J, Variend H, Kalakouti E, Kyprianou K. Cannabis and schizophrenia. Cochrane Database Syst Rev. 2014 Oct 14;(10):CD004837. doi: 10.1002/14651858.CD004837.pub3. Review. doi: 10.1002/14651858.CD007811.pub2. Review. doi: 10.1038/ajg.2013.118. Review. Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013 Jul 30;81(5):463-9. doi: 10.1212/WNL.0b013e31829d86b6. Review. Erratum in: Neurology. 2013 Nov 26;81(22):1968. Review. Russian. doi: 10.4088/JCP.12r07691. Review. Available from http://www.ncbi.nlm.nih.gov/books/NBK23684/ Available from http://www.ncbi.nlm.nih.gov/books/NBK65019/ Available from http://www.ncbi.nlm.nih.gov/books/NBK23408/ Available from http://www.ncbi.nlm.nih.gov/books/NBK22980/ Available from http://www.ncbi.nlm.nih.gov/books/NBK23195/ doi: 10.1093/schbul/sbr004. Epub 2011 Mar 21. Review.
    18: Leung K. (R)-(-)-2-Chloro-N-[1-(11)C-propyl]n-propylnorapomorphine. 2010 Oct 24 [updated 2010 Dec 11]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK50682/ doi: 10.1097/YCO.0b013e3283413505. Review. doi: 10.1016/j.schres.2010.07.012. Epub 2010 Aug 7. Review.

    合成参考文献


    参考文献:10.1007/s00535-005-1687-8
    摘要:Hojo M, Miwa H, Yokoyama T, Ohkusa T, Nagahara A, Kawabe M, Asaoka D, Izumi Y, Sato N. Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol. 2005 Nov;40(11):1036–42. doi: 10.1007/s00535-005-1687-8.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知